Tina M. Green

Reduced expression of <scp>TRIM</scp>21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease

Susanna Brauner, Wei Zhou, Carin Backlin et al. · Journal of Internal Medicine · 2015 · 64 citations · Full text

TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma

Suet Kee Loo, Ewe Seng Ch’ng, Md Salzihan Md Salleh et al. · Histopathology · 2017 · 44 citations

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas

Suet Kee Loo, Ewe Seng Ch’ng, Charles H. Lawrie et al. · Pathology · 2017 · 24 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +7

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

Kah Keng Wong, Duncan M. Gascoyne, Elizabeth J. Soilleux et al. · Oncotarget · 2016 · 21 citations · Full text

Hematological Malignancy, Tumor Biology, Distinct Biological Signatures +14

Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer

Sofie Traynor, Mie K. Jakobsen, Tina M. Green et al. · Journal for ImmunoTherapy of Cancer · 2024 · 16 citations · Full text

Immunology, Immunoediting, Tumor Biology +17